Cite Filings / CLDI / 0001193125-23-232609
Feed Companies Filings Check
Sign in
8-K

Current Report

Calidi Biotherapeutics, Inc. · Filed 2023-09-11 · Acc 0001193125-23-232609

Other events

  • Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , d515829d8k.htm

Around this filing

  • 2023-09-19 8-K Material agreement · Acquisition or sale completed · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change
  • 2023-09-14 4 10% owner disposed of 500,000 shares (other)
  • 2023-09-13 25-NSE Notification of Removal from Listing
  • 2023-09-11 8-K Other events
  • 2023-09-08 SC 13G Amended Statement of Ownership
  • 2023-09-08 SC 13G Amended Statement of Ownership
  • 2023-08-31 8-K Material agreement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading d515829d8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…